Found: 72
Select item for more details and to access through your institution.
Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs.
- Published in:
- Hepatology Research, 2024, v. 54, n. 11, p. 981, doi. 10.1111/hepr.14042
- By:
- Publication type:
- Article
Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02016-3
- By:
- Publication type:
- Article
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 2, p. 210, doi. 10.1002/jmv.25602
- By:
- Publication type:
- Article
The impact of interferon‐free direct‐acting antivirals on clinical outcome after curative treatment for hepatitis C virus–associated hepatocellular carcinoma: Comparison with interferon‐based therapy.
- Published in:
- Journal of Medical Virology, 2019, v. 91, n. 4, p. 650, doi. 10.1002/jmv.25352
- By:
- Publication type:
- Article
Advanced liver fibrosis effects on the response to sofosbuvir‐based antiviral therapies for chronic hepatitis C.
- Published in:
- Journal of Medical Virology, 2018, v. 90, n. 12, p. 1834, doi. 10.1002/jmv.25267
- By:
- Publication type:
- Article
Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.
- Published in:
- Yonago Acta Medica, 2023, v. 66, n. 4, p. 422, doi. 10.33160/yam.2023.11.007
- By:
- Publication type:
- Article
Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2023, v. 62, n. 12, p. 1771, doi. 10.2169/internalmedicine.9581-22
- By:
- Publication type:
- Article
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02616-z
- By:
- Publication type:
- Article
Reply from the authors.
- Published in:
- Hepatology Research, 2020, v. 50, n. 12, p. 1393, doi. 10.1111/hepr.13578
- By:
- Publication type:
- Article
Real‐world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus‐related decompensated cirrhosis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1234, doi. 10.1111/hepr.13555
- By:
- Publication type:
- Article
Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1222, doi. 10.1111/hepr.13554
- By:
- Publication type:
- Article
Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.
- Published in:
- Hepatology Research, 2020, v. 50, n. 7, p. 885, doi. 10.1111/hepr.13496
- By:
- Publication type:
- Article
Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2018, v. 48, n. 13, p. 1118, doi. 10.1111/hepr.13232
- By:
- Publication type:
- Article
Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus‐related cirrhosis.
- Published in:
- Hepatology Research, 2018, v. 48, n. 4, p. 264, doi. 10.1111/hepr.12996
- By:
- Publication type:
- Article
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.
- Published in:
- Hepatology Research, 2016, v. 46, n. 12, p. 1256, doi. 10.1111/hepr.12681
- By:
- Publication type:
- Article
Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.
- Published in:
- Hepatology Research, 2016, v. 46, n. 9, p. 944, doi. 10.1111/hepr.12629
- By:
- Publication type:
- Article
Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2015, v. 45, n. 6, p. 656, doi. 10.1111/hepr.12400
- By:
- Publication type:
- Article
Disseminated carcinomatosis of the bone marrow originating from hepatocellular carcinoma. A case report.
- Published in:
- Hepatology Research, 2015, v. 45, n. 6, p. 705, doi. 10.1111/hepr.12391
- By:
- Publication type:
- Article
Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2015, v. 45, n. 6, p. 607, doi. 10.1111/hepr.12392
- By:
- Publication type:
- Article
Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E420, doi. 10.1111/hepr.12330
- By:
- Publication type:
- Article
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E447, doi. 10.1111/hepr.12336
- By:
- Publication type:
- Article
Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib.
- Published in:
- Hepatology Research, 2014, v. 44, n. 13, p. 1320, doi. 10.1111/hepr.12307
- By:
- Publication type:
- Article
Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long-term outcomes in 14 patients.
- Published in:
- Hepatology Research, 2014, v. 44, n. 7, p. 740, doi. 10.1111/hepr.12181
- By:
- Publication type:
- Article
Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920922051
- By:
- Publication type:
- Article
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1328, doi. 10.3390/cancers16071328
- By:
- Publication type:
- Article
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5406, doi. 10.3390/cancers15225406
- By:
- Publication type:
- Article
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4234, doi. 10.3390/cancers15174234
- By:
- Publication type:
- Article
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2304, doi. 10.3390/cancers15082304
- By:
- Publication type:
- Article
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 846, doi. 10.3390/cancers15030846
- By:
- Publication type:
- Article
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 320, doi. 10.3390/cancers14020320
- By:
- Publication type:
- Article
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3958, doi. 10.3390/cancers13163958
- By:
- Publication type:
- Article
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 251, doi. 10.1159/000528145
- By:
- Publication type:
- Article
Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7025
- By:
- Publication type:
- Article
Correlation between serum pro‐inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1637, doi. 10.1111/jgh.16300
- By:
- Publication type:
- Article
Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 3, p. 592, doi. 10.1111/jgh.15766
- By:
- Publication type:
- Article
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 6, p. 1685, doi. 10.1111/jgh.15377
- By:
- Publication type:
- Article
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2278, doi. 10.1002/ijc.34247
- By:
- Publication type:
- Article
In vitro analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism.
- Published in:
- Molecular Medicine Reports, 2021, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune Pancreatitis.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 4, p. 1268, doi. 10.1007/s10620-020-06338-8
- By:
- Publication type:
- Article
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article